Prescott Group Capital Management’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.41M Hold
710,803
0.12% 172
2026
Q1
$903K Buy
710,803
+397,518
+127% +$748K 0.09% 190
2025
Q4
$749K Buy
+313,285
New +$857K 0.07% 221

Other funds holding HCAT

Prescott Group Capital Management's HCAT Position: Q2 2026 in Review

Prescott Group Capital Management held its Health Catalyst (HCAT) position steady in Q2 2026 at 710,803 shares worth $1.41M. The position accounts for 0.12% of the portfolio, ranked #172.

Prescott Group Capital Management first reported a position in HCAT in Q4 2025 and has held it in 3 quarters since. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Prescott Group Capital Management held 710,803 shares of Health Catalyst worth $1.41M as of Q2 2026.
  • Prescott Group Capital Management left its Health Catalyst share count unchanged in Q2 2026.
  • Health Catalyst made up 0.12% of Prescott Group Capital Management's portfolio in Q2 2026, its #172 holding.
  • Prescott Group Capital Management first reported a position in Health Catalyst in Q4 2025 and has held it in 3 quarters since.
  • 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Prescott Group Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.